{"transactions":[{"id":26189,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-03-04T22:00:13.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":600,"price":211.32,"value":126792.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.3 to $211.4, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6130,"source":{"system":"sec-edgar","filing":"0001415889-25-006580","document":"form4-03042025_050307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006580/form4-03042025_050307.xml","form_type":"4"}},{"id":26188,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-03-04T22:00:13.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":14973,"price":210.66,"value":3154212.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.25 to $211.23, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6730,"source":{"system":"sec-edgar","filing":"0001415889-25-006580","document":"form4-03042025_050307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006580/form4-03042025_050307.xml","form_type":"4"}},{"id":26187,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-03-04T22:00:13.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":5677,"price":209.8,"value":1191034.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.16 to $210, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":21703,"source":{"system":"sec-edgar","filing":"0001415889-25-006580","document":"form4-03042025_050307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006580/form4-03042025_050307.xml","form_type":"4"}},{"id":26186,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-03-04T22:00:13.000Z","date":"2025-02-28","kind":"tax_withholding","planned":true,"acquired":false,"shares":16904,"price":205.02,"value":3465658.08,"ownership":{"direct":true},"balance_after":27380,"source":{"system":"sec-edgar","filing":"0001415889-25-006580","document":"form4-03042025_050307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006580/form4-03042025_050307.xml","form_type":"4"}},{"id":26614,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"exercise","planned":true,"acquired":false,"shares":22210,"price":114.36,"value":2539935.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":114.36,"exercise_date":"2019-02-15","expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":22210},"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26613,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":4829,"price":203.63,"value":983329.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.55 to $203.68, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44284,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26612,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":13073,"price":202.92,"value":2652773.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.55 to $203.46, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49113,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26611,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":4308,"price":201.97,"value":870086.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.55 to $202.48, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":62186,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26610,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"exercise","planned":true,"acquired":true,"shares":22210,"price":114.36,"value":2539935.6,"ownership":{"direct":true},"balance_after":66494,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26609,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":1526,"price":203.64,"value":310754.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.58 to $203.65, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44284,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26608,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":4781,"price":202.93,"value":970208.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.58 to $203.56, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45810,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":26607,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-28T22:00:06.000Z","date":"2025-02-26","kind":"sale","planned":true,"acquired":false,"shares":1400,"price":202.06,"value":282884.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.58 to $202.45, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50591,"source":{"system":"sec-edgar","filing":"0001415889-25-006024","document":"form4-02282025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/form4-02282025_050201.xml","form_type":"4"}},{"id":28021,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2025-02-18T22:00:16.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":22916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,639 on February 13, 2026, 7,639 on February 13, 2027, and 7,638 on February 13, 2028."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,639 on February 13, 2026, 7,639 on February 13, 2027, and 7,638 on February 13, 2028."}],"balance_after":22916,"derivative":{"exercise_price":192.86,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":22916},"source":{"system":"sec-edgar","filing":"0001415889-25-004459","document":"form4-02182025_050209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/form4-02182025_050209.xml","form_type":"4"}},{"id":28020,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-18T22:00:16.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":6998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":51991,"source":{"system":"sec-edgar","filing":"0001415889-25-004459","document":"form4-02182025_050209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/form4-02182025_050209.xml","form_type":"4"}},{"id":28019,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-18T22:00:16.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":5792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":44993,"source":{"system":"sec-edgar","filing":"0001415889-25-004459","document":"form4-02182025_050209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/form4-02182025_050209.xml","form_type":"4"}},{"id":28018,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-18T22:00:16.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":7378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":39201,"source":{"system":"sec-edgar","filing":"0001415889-25-004459","document":"form4-02182025_050209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/form4-02182025_050209.xml","form_type":"4"}},{"id":28017,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2025-02-18T22:00:16.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":17986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":31823,"source":{"system":"sec-edgar","filing":"0001415889-25-004459","document":"form4-02182025_050209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/form4-02182025_050209.xml","form_type":"4"}},{"id":43989,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2024-03-05T22:30:50.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":false,"shares":45700,"price":61.36,"value":2804152.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":45700},"source":{"system":"sec-edgar","filing":"0001415889-24-006792","document":"form4-03052024_100336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/form4-03052024_100336.xml","form_type":"4"}},{"id":43988,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-03-05T22:30:50.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":20127,"price":177.71,"value":3576769.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.72 to $177.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13837,"source":{"system":"sec-edgar","filing":"0001415889-24-006792","document":"form4-03052024_100336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/form4-03052024_100336.xml","form_type":"4"}},{"id":43987,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-03-05T22:30:50.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":9853,"price":176.35,"value":1737576.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.76 to $176.69, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":33964,"source":{"system":"sec-edgar","filing":"0001415889-24-006792","document":"form4-03052024_100336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/form4-03052024_100336.xml","form_type":"4"}},{"id":43986,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-03-05T22:30:50.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":30288,"price":177.71,"value":5382480.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"he price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.77 to $177.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43817,"source":{"system":"sec-edgar","filing":"0001415889-24-006792","document":"form4-03052024_100336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/form4-03052024_100336.xml","form_type":"4"}},{"id":43985,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-03-05T22:30:50.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":15412,"price":176.4,"value":2718676.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.76 to $176.72, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":74105,"source":{"system":"sec-edgar","filing":"0001415889-24-006792","document":"form4-03052024_100336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/form4-03052024_100336.xml","form_type":"4"}},{"id":43984,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-03-05T22:30:50.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":true,"shares":45700,"price":61.36,"value":2804152.0,"ownership":{"direct":true},"balance_after":89517,"source":{"system":"sec-edgar","filing":"0001415889-24-006792","document":"form4-03052024_100336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/form4-03052024_100336.xml","form_type":"4"}},{"id":44466,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-03-01T22:50:20.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":23847,"price":178.99,"value":4268374.53,"ownership":{"direct":true},"balance_after":43817,"source":{"system":"sec-edgar","filing":"0001415889-24-006159","document":"form4-03012024_050311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006159/form4-03012024_050311.xml","form_type":"4"}},{"id":45407,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2024-02-20T22:20:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":28998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,666 on February 15, 2025, 9,666 on February 15, 2026, and 9,666 on February 15, 2027."}],"balance_after":28998,"derivative":{"exercise_price":0,"exercise_date":"2025-02-15","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":28998},"source":{"system":"sec-edgar","filing":"0001415889-24-004428","document":"form4-02202024_100233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/form4-02202024_100233.xml","form_type":"4"}},{"id":45406,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-02-20T22:20:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":5792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":67664,"source":{"system":"sec-edgar","filing":"0001415889-24-004428","document":"form4-02202024_100233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/form4-02202024_100233.xml","form_type":"4"}},{"id":45405,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-02-20T22:20:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":7380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":61872,"source":{"system":"sec-edgar","filing":"0001415889-24-004428","document":"form4-02202024_100233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/form4-02202024_100233.xml","form_type":"4"}},{"id":45404,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-02-20T22:20:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":8558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":54492,"source":{"system":"sec-edgar","filing":"0001415889-24-004428","document":"form4-02202024_100233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/form4-02202024_100233.xml","form_type":"4"}},{"id":45403,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2024-02-20T22:20:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":32097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":45934,"source":{"system":"sec-edgar","filing":"0001415889-24-004428","document":"form4-02202024_100233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/form4-02202024_100233.xml","form_type":"4"}},{"id":57887,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-03-02T21:30:36.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":16746,"price":153.62,"value":2572520.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.37 to $154.13, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13837,"source":{"system":"sec-edgar","filing":"0001415889-23-003820","document":"form4-03022023_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003820/form4-03022023_040302.xml","form_type":"4"}},{"id":57886,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-03-02T21:30:36.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":27395,"price":153.0784,"value":4193582.768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.37 to $153.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30583,"source":{"system":"sec-edgar","filing":"0001415889-23-003820","document":"form4-03022023_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003820/form4-03022023_040302.xml","form_type":"4"}},{"id":57885,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-03-02T21:30:36.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":35111,"price":154.28,"value":5416925.08,"ownership":{"direct":true},"balance_after":57978,"source":{"system":"sec-edgar","filing":"0001415889-23-003820","document":"form4-03022023_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003820/form4-03022023_040302.xml","form_type":"4"}},{"id":58497,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2023-02-21T23:00:33.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":21944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,315 on February 16, 2024, 7,315 on February 16, 2025, and 7,314 on February 16, 2026."}],"balance_after":21944,"derivative":{"exercise_price":149.62,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":21944},"source":{"system":"sec-edgar","filing":"0001415889-23-002936","document":"form4-02212023_110223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/form4-02212023_110223.xml","form_type":"4"}},{"id":58496,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-02-21T23:00:33.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":7380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":93089,"source":{"system":"sec-edgar","filing":"0001415889-23-002936","document":"form4-02212023_110223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/form4-02212023_110223.xml","form_type":"4"}},{"id":58495,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-02-21T23:00:33.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":8560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":85709,"source":{"system":"sec-edgar","filing":"0001415889-23-002936","document":"form4-02212023_110223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/form4-02212023_110223.xml","form_type":"4"}},{"id":58494,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-02-21T23:00:33.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":11977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":77149,"source":{"system":"sec-edgar","filing":"0001415889-23-002936","document":"form4-02212023_110223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/form4-02212023_110223.xml","form_type":"4"}},{"id":58493,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2023-02-21T23:00:33.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":51335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":65172,"source":{"system":"sec-edgar","filing":"0001415889-23-002936","document":"form4-02212023_110223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/form4-02212023_110223.xml","form_type":"4"}},{"id":60653,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2022-12-14T22:06:08.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":42370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":42370},"source":{"system":"sec-edgar","filing":"0001415889-22-012547","document":"form4-12142022_101246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588922012547/form4-12142022_101246.xml","form_type":"4"}},{"id":60652,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2022-12-14T22:06:08.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":3075,"price":164.1,"value":504607.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.08 to $164.18, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13837,"source":{"system":"sec-edgar","filing":"0001415889-22-012547","document":"form4-12142022_101246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588922012547/form4-12142022_101246.xml","form_type":"4"}},{"id":60651,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2022-12-14T22:06:08.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":39295,"price":163.39,"value":6420410.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $164.00, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16912,"source":{"system":"sec-edgar","filing":"0001415889-22-012547","document":"form4-12142022_101246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588922012547/form4-12142022_101246.xml","form_type":"4"}},{"id":60650,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common stock, $0.01 par value","published_at":"2022-12-14T22:06:08.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":42370,"price":54.86,"value":2324418.2,"ownership":{"direct":true},"balance_after":56207,"source":{"system":"sec-edgar","filing":"0001415889-22-012547","document":"form4-12142022_101246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588922012547/form4-12142022_101246.xml","form_type":"4"}},{"id":69862,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:09:25.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":2627,"price":149.0883,"value":391654.9641,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.905 to $149.46 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13837,"source":{"system":"sec-edgar","filing":"0001179110-22-001834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001834/edgar.xml","form_type":"4"}},{"id":69861,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:09:25.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":14424,"price":148.5854,"value":2143195.8096,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.91 to $148.90 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16464,"source":{"system":"sec-edgar","filing":"0001179110-22-001834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001834/edgar.xml","form_type":"4"}},{"id":69860,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:09:25.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":9381,"price":147.5235,"value":1383917.9535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.89 to $147.88 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30888,"source":{"system":"sec-edgar","filing":"0001179110-22-001834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001834/edgar.xml","form_type":"4"}},{"id":69859,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:09:25.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":21027,"price":149.54,"value":3144377.58,"ownership":{"direct":true},"balance_after":40269,"source":{"system":"sec-edgar","filing":"0001179110-22-001834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001834/edgar.xml","form_type":"4"}},{"id":70240,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-02-22T22:40:28.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":35026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,676 on February 17, 2023, 11,675 on February 17, 2024, and 11,675 on February 17, 2025."}],"balance_after":35026,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":35026},"source":{"system":"sec-edgar","filing":"0001179110-22-001516","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/edgar.xml","form_type":"4"}},{"id":70239,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:40:28.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":13837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of AbbVie common stock issued under a cliff vesting restricted stock unit award granted to the reporting person on February 17, 2022. The shares will vest in their entirety on the third anniversary of the grant date, subject to the reporting person's continued employment at AbbVie on such date."}],"balance_after":61296,"source":{"system":"sec-edgar","filing":"0001179110-22-001516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/edgar.xml","form_type":"4"}},{"id":70238,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:40:28.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":47459,"source":{"system":"sec-edgar","filing":"0001179110-22-001516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/edgar.xml","form_type":"4"}},{"id":70237,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:40:28.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":11978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":39969,"source":{"system":"sec-edgar","filing":"0001179110-22-001516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/edgar.xml","form_type":"4"}},{"id":70236,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:40:28.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":4998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":27991,"source":{"system":"sec-edgar","filing":"0001179110-22-001516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/edgar.xml","form_type":"4"}},{"id":70235,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:40:28.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":22993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":22993,"source":{"system":"sec-edgar","filing":"0001179110-22-001516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/edgar.xml","form_type":"4"}},{"id":74840,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Option (Right to buy)","published_at":"2021-12-08T22:01:21.000Z","date":"2021-12-06","kind":"exercise","acquired":false,"shares":50350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":58.88,"exercise_date":"2016-02-19","expiration_date":"2025-02-18","underlying":"Common stock","underlying_shares":50350},"source":{"system":"sec-edgar","filing":"0001179110-21-010695","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021010695/edgar.xml","form_type":"4"}},{"id":74839,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-12-08T22:01:21.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":50350,"price":120,"value":6042000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-21-010695","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021010695/edgar.xml","form_type":"4"}},{"id":74838,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-12-08T22:01:21.000Z","date":"2021-12-06","kind":"exercise","acquired":true,"shares":50350,"price":58.88,"value":2964608.0,"ownership":{"direct":true},"balance_after":50350,"source":{"system":"sec-edgar","filing":"0001179110-21-010695","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021010695/edgar.xml","form_type":"4"}},{"id":92084,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:31:59.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":19514,"price":108.5908,"value":2119040.8712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.285 to $108.83, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-21-002607","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002607/edgar.xml","form_type":"4"}},{"id":92083,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:31:59.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":15524,"price":107.74,"value":1672555.76,"ownership":{"direct":true},"balance_after":19514,"source":{"system":"sec-edgar","filing":"0001179110-21-002607","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002607/edgar.xml","form_type":"4"}},{"id":92736,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Option(right to buy)","published_at":"2021-02-22T23:23:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":42236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,079 on February 18, 2022, 14,079 on February 18, 2023, and 14,078 on February 18, 2024."}],"balance_after":42236,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common stock","underlying_shares":42236},"source":{"system":"sec-edgar","filing":"0001179110-21-002051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/edgar.xml","form_type":"4"}},{"id":92735,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":11978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":35038,"source":{"system":"sec-edgar","filing":"0001179110-21-002051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/edgar.xml","form_type":"4"}},{"id":92734,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":4998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":23060,"source":{"system":"sec-edgar","filing":"0001179110-21-002051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/edgar.xml","form_type":"4"}},{"id":92733,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":4105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":18062,"source":{"system":"sec-edgar","filing":"0001179110-21-002051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/edgar.xml","form_type":"4"}},{"id":92732,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":13957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":13957,"source":{"system":"sec-edgar","filing":"0001179110-21-002051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/edgar.xml","form_type":"4"}},{"id":97680,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Option (Right to buy)","published_at":"2020-12-01T22:22:54.000Z","date":"2020-11-27","kind":"exercise","acquired":false,"shares":51990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":51.42,"exercise_date":"2015-02-20","expiration_date":"2024-02-19","underlying":"Common stock","underlying_shares":51990},"source":{"system":"sec-edgar","filing":"0001179110-20-011502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020011502/edgar.xml","form_type":"4"}},{"id":97679,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-12-01T22:22:54.000Z","date":"2020-11-27","kind":"sale","acquired":false,"shares":51990,"price":105,"value":5458950.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-011502","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020011502/edgar.xml","form_type":"4"}},{"id":97678,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-12-01T22:22:54.000Z","date":"2020-11-27","kind":"exercise","acquired":true,"shares":51990,"price":51.42,"value":2673325.8,"ownership":{"direct":true},"balance_after":51990,"source":{"system":"sec-edgar","filing":"0001179110-20-011502","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020011502/edgar.xml","form_type":"4"}},{"id":104950,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-05-07T21:01:24.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":19445,"price":85,"value":1652825.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-005551","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020005551/edgar.xml","form_type":"4"}},{"id":106571,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-03-03T21:55:31.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":15462,"price":85.42,"value":1320764.04,"ownership":{"direct":true},"balance_after":19445,"source":{"system":"sec-edgar","filing":"0001179110-20-002860","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002860/edgar.xml","form_type":"4"}},{"id":107160,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Option (right to buy)","published_at":"2020-02-24T23:01:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":78559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,187 on February 20, 2021, 26,186 on February 20, 2022, and 26,186 on February 20, 2023."}],"balance_after":78559,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":78559},"source":{"system":"sec-edgar","filing":"0001179110-20-002132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002132/edgar.xml","form_type":"4"}},{"id":107159,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:01:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":4999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":34907,"source":{"system":"sec-edgar","filing":"0001179110-20-002132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002132/edgar.xml","form_type":"4"}},{"id":107158,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:01:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":4104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":29908,"source":{"system":"sec-edgar","filing":"0001179110-20-002132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002132/edgar.xml","form_type":"4"}},{"id":107157,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:01:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":6840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":25804,"source":{"system":"sec-edgar","filing":"0001179110-20-002132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002132/edgar.xml","form_type":"4"}},{"id":107156,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:01:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":18964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":18964,"source":{"system":"sec-edgar","filing":"0001179110-20-002132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002132/edgar.xml","form_type":"4"}},{"id":112350,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-10-01T21:52:42.000Z","date":"2019-09-27","kind":"sale","acquired":false,"shares":15515,"price":75.016,"value":1163873.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.02, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-052312","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465919052312/a4.xml","form_type":"4"}},{"id":118968,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-03-04T21:57:22.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":12345,"price":79.41,"value":980316.45,"ownership":{"direct":true},"balance_after":15515,"source":{"system":"sec-edgar","filing":"0001179110-19-003086","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019003086/edgar.xml","form_type":"4"}},{"id":119490,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Option (right to buy)","published_at":"2019-02-22T22:19:15.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":30763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,255 on February 21, 2020, 10,254 on February 21, 2021, and 10,254 on February 21, 2022."}],"balance_after":30763,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":30763},"source":{"system":"sec-edgar","filing":"0001179110-19-002367","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002367/edgar.xml","form_type":"4"}},{"id":119489,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:15.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":4105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":27860,"source":{"system":"sec-edgar","filing":"0001179110-19-002367","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002367/edgar.xml","form_type":"4"}},{"id":119488,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:15.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":6840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":23755,"source":{"system":"sec-edgar","filing":"0001179110-19-002367","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002367/edgar.xml","form_type":"4"}},{"id":119487,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:15.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":16915,"source":{"system":"sec-edgar","filing":"0001179110-19-002367","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002367/edgar.xml","form_type":"4"}},{"id":119486,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:19:15.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":9835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":9835,"source":{"system":"sec-edgar","filing":"0001179110-19-002367","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002367/edgar.xml","form_type":"4"}},{"id":127606,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2018-06-19T23:58:52.000Z","date":"2018-06-15","kind":"sale","acquired":true,"shares":17588,"price":99.4704,"value":1749485.3952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.19 to $99.58, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-008819","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018008819/edgar.xml","form_type":"4"}},{"id":131345,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:30:38.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":18129,"price":118.6746,"value":2151451.8234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.58 to $118.84, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17588,"source":{"system":"sec-edgar","filing":"0001179110-18-003338","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018003338/edgar.xml","form_type":"4"}},{"id":131344,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:30:38.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":12183,"price":118.26,"value":1440761.58,"ownership":{"direct":true},"balance_after":35717,"source":{"system":"sec-edgar","filing":"0001179110-18-003338","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018003338/edgar.xml","form_type":"4"}},{"id":132314,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Option (right to buy)","published_at":"2018-02-16T22:54:52.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":22210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 7,404 on February 15, 2019, 7,403 on February 15, 2020, and 7,403 on February 15, 2021."}],"balance_after":22210,"derivative":{"exercise_price":114.36,"exercise_date":"2019-02-15","expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":22210},"source":{"system":"sec-edgar","filing":"0001179110-18-002299","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002299/edgar.xml","form_type":"4"}},{"id":132313,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:54:52.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":6840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":47900,"source":{"system":"sec-edgar","filing":"0001179110-18-002299","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002299/edgar.xml","form_type":"4"}},{"id":132312,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:54:52.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":7902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":41060,"source":{"system":"sec-edgar","filing":"0001179110-18-002299","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002299/edgar.xml","form_type":"4"}},{"id":132311,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:54:52.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":33158,"source":{"system":"sec-edgar","filing":"0001179110-18-002299","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002299/edgar.xml","form_type":"4"}},{"id":134288,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Option (right to buy)","published_at":"2017-12-19T23:09:30.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":87040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":35.88,"exercise_date":"2016-02-14","expiration_date":"2023-02-13","underlying":"Common stock","underlying_shares":87040},"source":{"system":"sec-edgar","filing":"0001179110-17-015664","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017015664/edgar.xml","form_type":"4"}},{"id":134287,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2017-12-19T23:09:30.000Z","date":"2017-12-18","kind":"sale","acquired":false,"shares":87040,"price":98.4496,"value":8569053.184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.13 to $98.86, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26078,"source":{"system":"sec-edgar","filing":"0001179110-17-015664","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017015664/edgar.xml","form_type":"4"}},{"id":134286,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2017-12-19T23:09:30.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":87040,"price":35.88,"value":3122995.2,"ownership":{"direct":true},"balance_after":113118,"source":{"system":"sec-edgar","filing":"0001179110-17-015664","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017015664/edgar.xml","form_type":"4"}},{"id":142234,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2017-03-10T22:21:26.000Z","date":"2017-03-10","kind":"sale","acquired":false,"shares":22451,"price":65.29,"value":1465825.79,"ownership":{"direct":true},"balance_after":26078,"source":{"system":"sec-edgar","filing":"0001179110-17-004439","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017004439/edgar.xml","form_type":"4"}},{"id":142491,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2017-03-02T23:13:18.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":18902,"price":62.22,"value":1176082.44,"ownership":{"direct":true},"balance_after":48529,"source":{"system":"sec-edgar","filing":"0001179110-17-003704","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017003704/edgar.xml","form_type":"4"}},{"id":143028,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Option (right to buy)","published_at":"2017-02-21T22:52:00.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":45700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 15,234 on 02/16/2018, 15,233 on 02/16/2019, and 15,233 on 02/16/2020."}],"balance_after":45700,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common stock","underlying_shares":45700},"source":{"system":"sec-edgar","filing":"0001179110-17-002811","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017002811/edgar.xml","form_type":"4"}},{"id":143027,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2017-02-21T22:52:00.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017."}],"balance_after":67431,"source":{"system":"sec-edgar","filing":"0001179110-17-002811","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017002811/edgar.xml","form_type":"4"}},{"id":143026,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2017-02-21T22:52:00.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":15736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017."}],"balance_after":60351,"source":{"system":"sec-edgar","filing":"0001179110-17-002811","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017002811/edgar.xml","form_type":"4"}},{"id":152898,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2016-05-12T21:43:36.000Z","date":"2016-05-10","kind":"sale","acquired":false,"shares":21583,"price":63.52,"value":1370952.16,"ownership":{"direct":true},"balance_after":44615,"source":{"system":"sec-edgar","filing":"0001179110-16-024455","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911016024455/edgar.xml","form_type":"4"}},{"id":155262,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2016-03-02T22:23:47.000Z","date":"2016-03-01","kind":"sale","acquired":false,"shares":10792,"price":55,"value":593560.0,"ownership":{"direct":true},"balance_after":66198,"source":{"system":"sec-edgar","filing":"0001179110-16-020680","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911016020680/edgar.xml","form_type":"4"}},{"id":155261,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2016-03-02T22:23:47.000Z","date":"2016-02-29","kind":"sale","acquired":false,"shares":2074,"price":55.322,"value":114737.828,"ownership":{"direct":true},"balance_after":76990,"source":{"system":"sec-edgar","filing":"0001179110-16-020680","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911016020680/edgar.xml","form_type":"4"}},{"id":155260,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2016-03-02T22:23:47.000Z","date":"2016-02-29","kind":"tax_withholding","acquired":false,"shares":27890,"price":56,"value":1561840.0,"ownership":{"direct":true},"balance_after":79064,"source":{"system":"sec-edgar","filing":"0001179110-16-020680","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911016020680/edgar.xml","form_type":"4"}},{"id":155722,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Option (right to buy)","published_at":"2016-02-22T22:08:58.000Z","date":"2016-02-18","kind":"grant","acquired":true,"shares":42370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 14,124 on 02/18/2017, 14,123 on 02/18/2018, and 14,123 on 02/1/8/2019."}],"balance_after":42370,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common stock","underlying_shares":42370},"source":{"system":"sec-edgar","filing":"0001179110-16-019783","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911016019783/edgar.xml","form_type":"4"}},{"id":166093,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2015-03-03T23:07:53.000Z","date":"2015-03-02","kind":"sale","acquired":false,"shares":12314,"price":60.3,"value":742534.2,"ownership":{"direct":true},"balance_after":106954,"source":{"system":"sec-edgar","filing":"0001179110-15-004096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911015004096/edgar.xml","form_type":"4"}},{"id":166092,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11305,"kind":"person","name":"RICHMOND TIMOTHY J.","position":1,"cik":"0001563523","reported_name":"RICHMOND TIMOTHY J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common stock, $0.01 par value","published_at":"2015-03-03T23:07:53.000Z","date":"2015-02-28","kind":"tax_withholding","acquired":false,"shares":4592,"price":60.5,"value":277816.0,"ownership":{"direct":true},"balance_after":119268,"source":{"system":"sec-edgar","filing":"0001179110-15-004096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911015004096/edgar.xml","form_type":"4"}}],"next_cursor":"2015-03-03T23:07:53.000000Z,166092"}